Investor Relations
Investors
View the Latest Stock Trading Information
Review BioStem’s latest trading data, historical quotes, volume, and key statistics.
News
Sign Up with Email Alerts Today.
Get news, filings, and events directly in your inbox with our automated Email Alerts
Symbol
OTC : BSEMPrice
$Volume
Change
Investor Relations
BioStem Technologies
Press Releases
Latest News
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers Strategic head-to-head study of BR-AC vs. standard of care aims to demonstrate healing superiority potential to support increased payor coverage and market...
BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting
BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for UplistingNasdaq listing aims to increase market visibility and global liquidity opportunities as BioStem advances its commercial and clinical...
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO...